VJHemOnc is committed to improving our service to you

IMW 2019 | Myeloma: why PROMISE?

VJHemOnc is committed to improving our service to you

Annie Cowan

Annie Cowan, BA, Dana-Farber Cancer Institute, Boston, MA, outlines the aims, methods and results of the PROMISE study (NCT03689595), at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter